Tomeko — every condition, connected. Open full hub →
Home  /  Disease hubs  /  Neurofibromatosis, type 1

Neurofibromatosis, type 1

Specialists and centers, recruiting clinical trials, patient organizations, research, and community for Neurofibromatosis, type 1 — brought together in one place.

Open the full interactive hub for Neurofibromatosis, type 1 →

Just diagnosed with Neurofibromatosis, type 1?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Neurofibromatosis, type 1, look for clinical trials, and connect with others living with it — all in one place.

Open the full interactive Neurofibromatosis, type 1 hub →

Overview

Neurofibromatosis, type 1 is a rare condition. Also known as Nonmosaic NF1, Nonmosaic neurofibromatosis type 1, Von Recklinghausen disease. Tomeko brings together the specialists, research, clinical trials, treatments and community for Neurofibromatosis, type 1 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:636 · OMIM 162200, 162210, 613675 · ICD-10 Q85.0 · GARD 0007866

Find care for Neurofibromatosis, type 1

Authoritative references for Neurofibromatosis, type 1

Research & market landscape for Neurofibromatosis, type 1

Following Neurofibromatosis, type 1 for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Neurofibromatosis, type 1 — the real-world landscape behind the condition, in one place.

Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Neurofibromatosis, type 1 and every rare condition. See how Tomeko works with industry →

Common questions

What is Neurofibromatosis, type 1?

Neurofibromatosis, type 1 is a rare condition. Also known as Nonmosaic NF1, Nonmosaic neurofibromatosis type 1, Von Recklinghausen disease. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Neurofibromatosis, type 1 together in one place.

What are the symptoms of Neurofibromatosis, type 1?

Symptoms of Neurofibromatosis, type 1 vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Neurofibromatosis, type 1.

How is Neurofibromatosis, type 1 treated?

Treatment for Neurofibromatosis, type 1 depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Neurofibromatosis, type 1, and review current options with them.

What causes Neurofibromatosis, type 1 — is it genetic?

The cause and inheritance of Neurofibromatosis, type 1 are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Neurofibromatosis, type 1 can explain what it means for you and your family.

I was just diagnosed with Neurofibromatosis, type 1 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Neurofibromatosis, type 1, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Neurofibromatosis, type 1?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Neurofibromatosis, type 1, filtered to your area.

Are there clinical trials for Neurofibromatosis, type 1?

Tomeko shows live, recruiting studies for Neurofibromatosis, type 1 from ClinicalTrials.gov on the hub.

Related conditions

Other conditions on Tomeko you may be looking for: